Application of pterostilbene in preparation of host intestinal flora regulator for resisting salmonella infection
By using Salmonella as a host microbiota regulator, Salmonella significantly inhibited and upregulated the beneficial bacteria in intestinal bacteria in mice, the problem of drug resistance in Salmonella infection was solved and a new treatment strategy for reducing antibiotic dependence was provided.
Patent Information
- Application Number
- CN202411103617.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-08
AI Technical Summary
The problem of drug resistance of existing antibiotics to treat Salmonella infection is becoming increasingly serious, and new anti-infection strategies and drugs are urgently needed to prevent and treat Salmonella infection.
The abundance of beneficial bacterial flora was used as the host bacterial flora regulator, and it was screened through animal tests and confirmed that it had a significant inhibitory effect on Salmonella, and upregulated the abundance of beneficial bacterial flora in the intestine of mice to reduce Salmonella infection.
The sarcoidae significantly reduced the colony colonization number of Salmonella in the mouse target organs, and the minimum inhibitory concentration of Salmonella is higher than 256μg/mL, which does not affect Salmonella growth, and provides a new antibiotic that is not dependent on the target host. Effect strategy.
Smart Images

Figure CN118903073A_ABST
